55 results
8-K
EX-99.1
SYBX
Synlogic, Inc.
9 Nov 23
Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:44am
metabolites transit through the GI tract, providing validated targets for these Synthetic Biotics. Research activities include a partnership
8-K
EX-99.1
ecbg8
7 Nov 23
Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration
6:45am
424B4
1zk jtwhtu9uc
2 Oct 23
Prospectus supplement with pricing info
5:05pm
8-K
EX-99.1
4mja9rick0ee1lsr
29 Sep 23
Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering
8:53am
8-K
EX-99.1
t4qu ruh7i0g6zlexz1
28 Sep 23
Synlogic Announces Reverse Stock Split
4:15pm
8-K
EX-99.1
fx89921 lg62
10 Aug 23
Synlogic Reports Second Quarter 2023 Financial Results and Provides Business Update
6:35am
8-K
EX-99.1
r3ibw706xr8
5 Jun 23
Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria
8:32am